Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Critical role of phase I clinical trials in cancer treatment. American Society of Clinical Oncology.

Literature DB >> 9053513

Critical role of phase I clinical trials in cancer treatment. American Society of Clinical Oncology.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 1997 PMID： 9053513 DOI： 10.1200/JCO.1997.15.2.853

Source DB: PubMed Journal: J Clin Oncol ISSN： 0732-183X Impact factor: 44.544

Keyword Cloud
Cited

× No keyword cloud information.

13 in total

1. Extending clinical equipoise to phase 1 trials involving patients: unresolved problems.

Authors: James A Anderson; Jonathan Kimmelman
Journal: Kennedy Inst Ethics J Date: 2010-03

2. How do researchers decide early clinical trials?

Authors: Hannah Grankvist; Jonathan Kimmelman
Journal: Med Health Care Philos Date: 2016-06

3. American Society of Clinical Oncology policy statement update: the critical role of phase I trials in cancer research and treatment.

Authors: Jeffrey S Weber; Laura A Levit; Peter C Adamson; Suanna Bruinooge; Howard A Burris; Michael A Carducci; Adam P Dicker; Mithat Gönen; Stephen M Keefe; Michael A Postow; Michael A Thompson; David M Waterhouse; Susan L Weiner; Lynn M Schuchter
Journal: J Clin Oncol Date: 2014-12-15 Impact factor: 44.544

Review 4. Early-Phase Platform Trials: A New Paradigm for Dose Finding and Treatment Screening in the Era of Precision Oncology.

Authors: Mei-Yin C Polley; Ying Kuen Cheung
Journal: JCO Precis Oncol Date: 2019-10-24

5. Phase I oncology studies: evidence that in the era of targeted therapies patients on lower doses do not fare worse.

Authors: Rajul K Jain; J Jack Lee; David Hong; Maurie Markman; Jing Gong; Aung Naing; Jennifer Wheler; Razelle Kurzrock
Journal: Clin Cancer Res Date: 2010-02-09 Impact factor: 12.531

6. Attitudinal barriers to participation in oncology clinical trials: factor analysis and correlates of barriers.

Authors: S Manne; D Kashy; T Albrecht; Y-N Wong; A Lederman Flamm; A B Benson; S M Miller; Linda Fleisher; J Buzaglo; N Roach; M Katz; E Ross; M Collins; D Poole; S Raivitch; D M Miller; T G Kinzy; T Liu; N J Meropol
Journal: Eur J Cancer Care (Engl) Date: 2014-01-28 Impact factor: 2.520

Critical role of phase I clinical trials in cancer treatment. American Society of Clinical Oncology.

1. Extending clinical equipoise to phase 1 trials involving patients: unresolved problems.

2. How do researchers decide early clinical trials?

3. American Society of Clinical Oncology policy statement update: the critical role of phase I trials in cancer research and treatment.

Review 4. Early-Phase Platform Trials: A New Paradigm for Dose Finding and Treatment Screening in the Era of Precision Oncology.

5. Phase I oncology studies: evidence that in the era of targeted therapies patients on lower doses do not fare worse.

6. Attitudinal barriers to participation in oncology clinical trials: factor analysis and correlates of barriers.

7. Clinical Outcomes of Patients With Gastrointestinal Malignancies Participating in Phase I Clinical Trials.

8. The changing face of phase 1 cancer clinical trials: new challenges in study requirements.

9. Proportion of Patients in Phase I Oncology Trials Receiving Treatments That Are Ultimately Approved.

10. Predicting harms and benefits in translational trials: ethics, evidence, and uncertainty.